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Abstract
Background: Nijmegen breakage syndrome is an autosomal recessive disorder characterized by microcephaly,
immunodeficiency, hypersensitivity to X-irradiation, and a high predisposition to cancer. Nibrin, the product of the
NBN gene, is part of the MRE11/RAD50 (MRN) complex that is involved in the repair of DNA double strand breaks
(DSBs), and plays a critical role in the processing of DSBs in immune gene rearrangements, telomere maintenance,
and meiotic recombination. NBS skin fibroblasts grow slowly in culture and enter early into senescence.
Case presentation: Here we present an incidental finding. Skin fibroblasts, derived from a 9 year old NBS patient,
showed a mosaic of normal diploid cells (46,XY) and those with a complex, unbalanced translocation. The aberrant
karyotype was analysed by G-banding, comparative genomic hybridization, and whole chromosome painting. The
exact breakpoints of the derivative chromosome were mapped by whole genome sequencing: 45,XY,der(6)(6pter→
6q11.1::13q11→ 13q21.33::20q11.22→ 20qter),-13. The deleted region of chromosomes 6 harbors almost 1.400 and that
of chromosome 13 more than 500 genes, the duplicated region of chromosome 20 contains about 700 genes. Such
unbalanced translocations are regularly incompatible with cellular survival, except in malignant cells. The aberrant cells,
however, showed a high proliferation potential and could even be clonally expanded. Telomere length was significantly
reduced, hTERT was not expressed. The cells underwent about 50 population doublings until they entered into
senescence. The chromosomal preparation performed shortly before senescence showed telomere fusions,
premature centromere divisions, endoreduplications and tetraploid cells, isochromatid breaks and a variety of
marker chromosomes. Inspection of the site of skin biopsy 18 years later, presented no evidence for abnormal
growth.
Conclusions: The aberrant cells had a significant selective advantage in vitro. It is therefore tempting to speculate that
this highly unbalanced translocation could be a primary driver of cancer cell growth.
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Background
Nijmegen breakage syndrome (NBS) is an autosomal re-
cessive disorder characterized by chromosome instability
associated with microcephaly, immunodeficiency, hyper-
sensitivity to X-irradiation, and a high predisposition to
cancer. The majority of NBS patients are of Central and
Eastern European origin and carry the common founder
mutation in the NBN (NBS1) gene, c.657_661del5 [1–3].
By the age of 20 years more than 40% of patients have
developed a malignant disease, predominantly of lymph-
oid origin [4–6]. Even heterozygous carriers of the
founder mutation have an increased cancer risk [7, 8].
Nibrin, the product of the NBN gene, is part of the
MRE11/RAD50 (MRN) complex that is involved in the
repair of DNA double strand breaks (DSBs), both by
homologous recombination repair (HRR) and non-
homologous end-joining (NHEJ). Moreover, the NBN
gene plays a critical role in the processing of DSBs in
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immune gene rearrangements, telomere maintenance,
and meiotic recombination [9–11]. Thus, almost all as-
pects of the DNA damage response (DDR), including
apoptosis, are affected [12].
NBS skin fibroblasts grow slowly in culture and enter
early into senescence. Consequently, they have a low
reprogramming efficiency into induced pluripotent stem
cells (iPSCs) [13]. The iPSCs show, amongst others, nu-
merous chromosomal aberrations, a delayed response to
DSB induction, slower growth rate, and a reduced apop-
totic response to stress [14].
Here we present a, perhaps unique, incidental finding.
Skin fibroblasts, derived from a 9 years old NBS patient
showed a mosaic of normal diploid cells and those with
a complex, unbalanced translocation, leading to the loss
and duplication of hundreds of genes. Such primary
events are regularly incompatible with cellular survival.
Unexpectedly, these cells showed a high proliferation
potential in vitro and could even be cloned. Thus, this
complex aberration might represent an early (first) step
toward malignant transformation.
Case presentation
The skin biopsy was obtained from a 9 years old Polish
child with NBS. He presented all phenotypic characteris-
tics of NBS, i.e. microcephaly and typical facial features,
recurring pulmonary infections, bronchiectasis, and
combined humoral and cellular immunodeficiency. The
cell line was established with the ethical approval of The
Children’s Memorial Health Institute, Warsaw. At the
age of 21 years the patient underwent total thyroidec-
tomy (papillary thyroid carcinoma, follicular variant).
The patient was under systematic longitudinal observa-
tion and treatment at The Children’s Memorial Health
Institute from the age of 9 until 21 years. The patient
was contacted again at the age of 27 years. There was
only a scar at the site of the skin biopsy without any evi-
dence of abnormal growth.
Results
The fibroblast cell line (94P0496) was derived from the
NBS patient, homozygous for the common founder
mutation in the NBN gene, a five-base-pair deletion,
c.657_661del5 in exon 6, that leads to two truncated
protein fragments, p26- and p70 Nibrin. After chromo-
some analysis two cell lines could be identified, one with
a normal diploid karyotype, 46,XY, the other with 45
chromosomes. The latter had only one chromosome 6
and 13 plus a derivative chromosome (Fig. 1).
As shown by whole chromosome painting (WCP) the
p-arm including the centromere of the derivative
chromosome is from chromosome 6, the proximal part
of the long arm from chromosome 13 to which the q-
arm of chromosome 20 is attached, resulting in partial
monosomy of chromosome 6 and 13 and partial trisomy
of chromosome 20 (Fig. 2). This was confirmed by com-
parative genomic hybridization (CGH, Fig. 2).
The exact breakpoints were mapped by whole genome
sequencing (WGS; Additional file 1: Figure S1a,b). The
breakpoint on the derivative chromosome 6 is on 6q at
chr6:63,015,229. Attached to this breakpoint is a
chromosome 13-specific satellite I DNA, mapped to
chromosome 13 in 13p13 and the pericentromeric
Fig. 1 Karyotype of the aberrant NBS line 94P0496 after G-banding. The arrows point to the derivate chromosome and the one chromosome 13.
The chromosomal preparation was performed after cloning, i.e. after about 40 cell divisions. The Y chromosome has been lost during cultivation
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region [15]. The distal breakpoint on chromosome 13 is
at chr13:71,189,298 followed by the translocated seg-
ment of the q-arm of chromosome 20 starting at pos-
ition chr20:34,287,131 to 20qter. Based on FISH analysis
with the XL acro-p probe and G-banding there was no
evidence for an interstitial short arm of chromosome 13.
Thus, we assume that the break was in the subcentro-
meric band at 13q1.1. The karyotype of this complex
unbalanced translocation according to ISCN is:
45,XY,der(6)(6pter→ 6q11.1::13q11→ 13q21.33::20q11.2
2→ 20qter),-13. The deleted region of chromosome 6
harbors 1.397 genes, the deleted region of chromosome
13 contains 543 genes, and the duplicated region of
chromosome 20 encompasses 710 genes (Fig. 3). Such
unbalanced translocations are regularly incompatible
with cellular survival, except in malignant cells.
The cell cycle length was analysed after BrdU labelling
for 36 and 72 h. Based on the labelling pattern of the
sister chromatids (Additional file 1: Figure S2), the dip-
loid and aberrant cells were classified if they had passed
one, two or three S-phases after labelling (Table 1). The
number of M2 cells after 36 h and of M3 cells after 72 h
was significantly higher for the aberrant cells and conse-
quently their cell cycle was shorter than that of the dip-
loid cells (P < 0.05).
The cells were classified if they had passed one (M1),
two (M2) or three S-phases (M3) after labelling. The ab-
errant cells underwent significantly more cell divisions
than those with the normal karyotype (Fisher’s exact
test, P < 0.05; Original from [16]).
At an early passage the diploid and aberrant cells
were analysed for chromosomal aberrations after ir-
radiation in G2-phase with 0 Gy, 0.5 Gy and 1.0 Gy.
About 20 normal and 40 aberrant cells were analysed
each. The types of aberrations were classified as
achromatic lesions, chromatid and isochromatid
Fig. 2 Characterization of the aberrant line 94P0496 after comparative genomic hybridization and whole chromosome painting. Above: CGH
analysis of the aberrant cell line 94P0496 showing partial monosomy for the q arms of chromosome 6 and 13 and partial trisomy for chromosome 20.
Below: Metaphase with marker chromosome (white arrow) after whole chromosome painting. A: chromosome 20 in green; B: chromosomes 13 in red
and 6 in green (Original from [16])
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breaks, and chromatid translocation (Additional file 1:
Figure S3). In order to calculate the total number of
chromatid breaks per cell the latter were counted
twice, the achromatic lesions neglected. The number
of chromosomal aberrations was significantly higher
in the aberrant cells than in the normal ones after ir-
radiation (P < 0.05; Table 2). Thus, chromosomal in-
stability of the aberrant line was not decreased but
increased.
The aberrant cells showed more aberrations than
those with the normal diploid karyotype (Chi-square
test, P < 0.05; Original from [16]).
Moreover, telomere length (T/C value) was mea-
sured by Q-FISH in 94P0496 and two other NBS
fibroblast lines in comparison with 2 control fibro-
blast cell lines at passage 7. The telomere length was
significantly longer in the controls than in the NBS-
fibroblasts (P < 0.05) with median values (T/C values)
of 87.9 and 87.5 for the controls and 48.5 for
94P0496 (Fig. 4). Thus, the T/C value of 94P0496 was
reduced to about 55%. In addition, the absolute telo-
mere length was measured by Terminal Restriction
Fragment (TRF) analysis. This technique is based on
Southern blots and also included the subtelomeric re-
gion. The NBS fibroblasts had a telomere length of
about 12.5 kb compared to about 17 kb for the con-
trol fibroblast [16]. There was no detectable hTERT
expression in the NBS cell line 94P0496 in contrast
to two SV40 transformed NBS cell lines (Additional
file 1: Figure S4).
The cells were cultivated until they reached senes-
cence in two independent culture attempts. Regularly
some subcultures were kept confluent for several
weeks to test if some cells escaped contact inhibition.
This, however, was not the case. In the second
attempt, the cells were cloned and fourteen clones
propagated. Thirteen clones were diploid, one tetra-
ploid, all contained the derivative chromosome 6 and
one normal chromosome 13 (Fig. 1). After confluency
the cultures were split at a 1:4 ratio until the cells
entered into senescence six to ten passages later.
Altogether we calculate that the cells underwent
about 50 cell divisions until they reached senescence,
i.e. at least ten division after establishment of the cell
line from tissue pieces until the cells could be propa-
gated for the first time. After four passages they were
cloned. Thereafter, the cells underwent at least 20 cell
divisions until the flasks were confluent. After further
12 to 20 cell divisions the cells entered into
senescence.
The first chromosomal preparation was performed
when the cells were still in logarithmic growth and three
G-banded metaphases were analysed each. Only three
clones showed in at least two metaphases the original
karyotype. The others had additional aberrations, such
as telomere fusions and marker chromosomes (Fig. 5).
In seven of the 42 metaphases the Y chromosome has
been lost. Shortly before the cells entered into senes-
cence the second chromosome preparation was per-
formed. Only in eleven of the fourteen clones some
metaphases could be found. All had complex aberra-
tions, such as premature centromere divisions, endore-
duplications, tetraploidizations, isochromatid breaks,
and a variety of marker chromosomes (Fig. 6).
The examination of the patient 18 years later showed
no abnormal growth at the site of the skin biopsy
(Fig. 7).
Table 1 Analysis of metaphases of the 94P0496 cell line after 36











36 h M1 5 3 2
M2 50 48 2
72 h M1 0 0 0
M2 16 13 3
M3 34 34 0
Fig. 3 Reconstruction of the derivative chromosome after whole genome sequencing. The exact breakpoints are depicted and the number of
deleted and duplicated genes indicated (NCBI, Map Viewer, Annotation Release 108)
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Discussion
The MRN complex is central to the maintenance of gen-
omic stability by the DNA damage response (DDR) net-
work, which is, amongst others, involved in cell cycle
checkpoint control, telomere maintenance, and apoptosis.
Thus, NBS patients with defective DDR show a highly in-
creased cancer risk due to their massive genetic/chromo-
somal instability. This leads to a large number of
genetically different cells from which those capable of
continual proliferation will be selected. Clearly, human
tumor cells often show gross chromosomal abnormalities.
The question, however, is whether these changes are pri-
mary events or secondary epiphenomena reflecting the
genomic instability of these cells [17, 18]. Without any
doubt, the growth advantages conveyed by specific
chromosomal translocations as in chronic myelogenous
leukemia and Burkitt’s lymphoma leading to oncogenic fu-
sion proteins or overexpression of oncogenes are primary
drivers of cell growth. The prevailing view, however, is
that most of the complex chromosomal changes of malig-
nant cells are secondary events. In this context the aber-
rant NBS fibroblast cell line is of special interest. The
percentage of these cells increased during cultivation and
they replaced the diploid cells, which is, at least partially,
explained by its shorter cell cycle. Clearly, this line had a
selective advantage in tissue culture, even despite its
increased chromosomal instability. Moreover, these cells
could be cloned. This is in contrast to NBS skin fibro-
blasts, which grow slowly in culture, enter early into sen-
escence and have an extremely low reprogramming
efficiency [13]. There are strong arguments for the
assumption that the derivative chromosome is the crucial,
primary event for the selective advantage of this cell line
against the NBS background. It was the only cytogenetic
aberration detected immediately after establishment of the
cell culture. At the third passage after establishment about
50% of the cells showed the aberrant karyotype, which
continuously took over. The derivative chromosome was
also present in all 14 clones until senescence.
This complex chromosomal translocation results from
the rearrangements between three chromosomes. Such
events depend on DNA double-strand breaks and misre-
pair of the broken chromatin ends [19]. The major DNA
repair pathways are Homologous Recombination (HR)
and Non-homologous End-Joining (NHEJ) [20]. HR uti-
lizes sister chromatids as a template and is error proof,
while the NHEJ process directly ligates the broken DNA
ends and is error prone. The flanking sequences of the
translocation breakpoints did not show any alterations
(see Additional file 1: Figure S1a, b) pointing to HR as
possible underlying mechanism.
The telomere length was reduced in the aberrant cell
line which is a characteristic of NBS cells in general [21].
Quite surprisingly these cells underwent about 50 cell
divisions until they entered into senescence. Telomerase
was not expressed, however, we cannot exclude that a
telomere maintenance pathway, such as alternative
lengthening of telomeres (ALT), was at least temporarily
activated. Clearly, the telomeres became shorter during
cultivation. The shortened telomere ends are signaled as
DSBs leading to telomere fusions and chromosomes
with two centromeres in the NBS cells. This results in
breakage-fusion-bridge cycles, because the different cen-
tromeres may be pulled in opposite directions during
anaphase [20]. Thus, the cells acquired numerous add-
itional, non-recurrent chromosomal aberrations apart
from those that are due to the inherent chromosomal in-
stability. Interestingly, this took place already during the
Table 2 Analysis of chromosomal breaks in normal and aberrant cells of the 94P0496 cell line after irradiation
Dose 94P0496 cells Metaphases analysed Chromatid breaks Chromatid translocat. Chromos. breaks Total Breaks Breaks/ metaphase
0 Gy normal 23 5 – – 5 0.22
aberrant 42 10 – 2 12 0.29
0.5 Gy normal 20 23 – 6 29 1.45
aberrant 42 53 4 9 66 1.57
1.0 Gy normal 21 39 – 10 49 2.3
aberrant 43 125 6 13 144 3.4
Fig. 4 Boxplots of telomere lengths of normal diploid and NBS-
fibroblasts. The telomere length (T/C value) of the three NBS cell
lines, incl. 94P0496, is significantly shorter than that of the two
normal fibroblast cell lines, tested at passage 7 (Mann-Whitney
test; P < 0.05; Original from [16])
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phase of logarithmic cell growth (see Fig. 5). In contrast
to normal diploid cells, in the aberrant cells the DDR
did not trigger the pathway to apoptosis. The impair-
ment of apoptosis and cell cycle checkpoint control is a
hallmark of NBS cells in general and was also observed
in induced pluripotent stem cells after reprogramming
NBS fibroblasts [14]. It could be at least one explanation
for the late entry into senescence. However, faced with
the enormous imbalance generated by the origin of the
derivative chromosome, the observed massive growth
advantage is still an open question.
Almost 2.000 genes were lost and 710 genes from
chromosome 20 gained. Gain of chromosome 20 is fre-
quently observed in colorectal carcinomas and malignant
epithelial tumors [22, 23]. Moreover, the combination of
gains of 20q and losses of 6q and 13q is common in oral
squamous cell carcinomas [24]. The duplicated 20q region
contains the putative oncogenes AURKA and ZNF217, as
well as the transcription factor E2F1 that is involved in
DSB repair in association with the MRN complex [25].
Loss of the IGF2R on 6q increases the growth of human
and murine tumors [26]. It should be noted that loss of
chromosome 14 confers a growth advantage to NBS-
iPSCs [14]. These few examples, however, only illustrate
how gains and losses of specific genes/chromosomes
could influence cell proliferation and malignant trans-
formation. In this context it is of interest that a high fre-
quency of spontaneous, nonspecific, and even complex
Fig. 5 Pattern of chromosomal aberrations, especially telomere fusions, observed in the aberrant clones during log. growth
Fig. 6 Pattern of chromosomal aberrations observed in the aberrant
clones immediately before entering into senescence. A: multiple
isochromatid breaks; B: triradial; C: two dicentric chromosomes (telomere
fusion); D: endoreduplication; E and F: premature centromere division
Fig. 7 Scar after skin biopsy 18 years before. There is no evidence
for abnormal growth
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translocations were found in lymphocytes and lympho-
blastoid cell lines from NBS patients. Moreover, exactly as
in our case two clones with such a translocation showed
an increased rate of proliferation and the authors pointed
out that such clones could serve as an in vitro model for
tumorigenesis [27].
Conclusions
(Partial) aneuploidy of single chromosomes is detri-
mental to diploid cells, but could be “beneficial” in can-
cer cells. Most solid cancer show large-scale
chromosomal alterations and it is generally accepted
that some are functionally important (cancer drivers)
whilst others represent only random changes. Based on
our findings we come to the conclusion that the deriva-
tive chromosome might be a driver aberration and rep-
resent an early (first) step in malignant transformation
against the NBS background of chromosomal instabil-
ity. This premise, however, can be tested empirically by
reconstitution of telomerase activity in these cells and
study if this combination of the derivative chromosome
and telomerase confers a tumorigenic phenotype, just
in line with the statement of Bunting and Nussenzweig
[17] “Making sense of how translocations influence
cancer cell growth will be a major topic of research
interest in the coming years.”
Methods
Cytogenetics
The fibroblast were grown and cloned in Amniomax
medium at 37 °C and 5% CO2, supplemented with the
usual amount of antibiotics.
G-banded metaphases were prepared according to
standard clinical laboratory procedures. Comparative
genomic hybridization (CGH) and whole chromosome
painting (WCP) was performed according to Tönnies et
al. [28]. Fluorescence in situ hybridization (FISH) was
performed with the XL acro-p probe, which specifically
hybridize to the p-arms of all human acrocentric chro-
mosomes, according to manufacturer’s instruction
(MetaSystems). The length of telomeres was measured
by quantitative fluorescence in situ hybridization of telo-
mere repeats (Q-FISH) according to Perner et al. [29]. It
is based on the fluorescence intensity of single telomeres
(T) relative to a constant repetitive region in the centro-
meric region of chromosome 2 (C). The T/C ratio re-
flects the relative length of individual telomeres. In
addition, the total relative length of all chromosomes
was estimated.
Based on Bromodeoxyuridine labeling (BrdU) for 36 h
and 72 h the number of cells in the first, second and
third mitosis was analyzed after Hoechst 33,258 staining
using a florescence microscope (Axioscope) and the soft-
ware of Metasystems. The number of chromosomal
aberrations was calculated 4 h after X-irradiation with
0.5 and 1.0 Gy (Muller MG 150 X ray apparatus; UA,
100 kV; I, 10 mA; filter, 0.3 mm Ni; dose rate 2.1 Gy/
min), including 2 h Colcemid treatment.
Molecular genetics
The NBN founder mutation was studied by means of
exon 6 PCR and sequencing.
Absolute telomere length was measured by Terminal Re-
striction Fragment (TRF) length analysis, performed ac-
cording to the standard manufacturer’s instruction of
Roche (TeloTAGGG telomere length assay). The protocol
involved DNA cutting into fragments by a mixture of fre-
quently cutting restriction enzymes: Hinf1 and Rsa1, separ-
ating the fragments by gel electrophoresis, and blotting on
a nylon membrane. The blotted DNA fragments were hy-
bridized to a digoxigenin (DIG)-labeled probe specific for
telomeric repeats, incubated with a DIG-specific antibody,
exposed to an x-ray film to estimate the mean TRF length.
Expression of the human telomerase reverse tran-
scriptase gene (hTERT) was analyzed by qPCR. The
hTERT cDNA was synthesized according to the standard
manufacture’s instruction (Invitrogen). GAPDH (glycer-
aldehyde-3-phosphatedehydrogenase) was used as an in-
ternal, HPRT (guanine phosphoribosyl transferase) as
endogenous control gene. All PCRs were performed on
Applied Biosystem prism 7500 (software DSD V1.2.3).
The qPCR products were checked by agarose gel elec-
trophoresis, visualized by UV-transilluminator and
photographed.
Detailed protocols of the cytogenetic and molecular
genetic methods are presented in Habib, 2012 [16].
Whole genome sequencing was performed using the
Illumina X Ten platform. Purified DNA was quantified
using the Qubit Broad Range double-stranded DNA
assay (Life Technologies, Carlsbad, CA, USA). Genomic
DNA was sheared using an S2 Ultrasonicator (Covaris,
Woburn, MA, USA). Whole- genome sequencing and li-
brary preparations were performed according to the
manufacturer’s instructions (Illumina, San Diego, CA,
USA or NEBNext, NEB). The quality of the libraries was
assessed using a Bioanalyzer (Agilent, Stockport, UK).
Statistical tests
The original data were exported to Excel 2007, Graph-
Pad Prism 5 software and SPSS15.0 software for graphs
and boxplots, statistical tests as Mann-Whitney, Fisher’s
exact and Chi- square test.
Additional file
Additional file 1: Figure S1a,b. Alignment of the cDNA spanning the
breakpoints at chromosomes 6 and 13 and chromosomes 13 and 20.
Figure S2. Metaphases of the NBS cell line after BrdU labelling for 36 and
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72 h. Figure S3. Metaphase of the NBS cell line after irradiation with
1.0 Gy. Figure S4 hTERT expression in diploid NBS-fibroblasts and SV40
transformed NBS cell lines. (DOCX 1.44 mb)
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